Acura Pharmaceuticals Reports Second Quarter 2010 Financial Results
News | 29 July 2010
The results include revenues relating to our License, Development and Commercialization Agreement with King Pharmaceuticals Research and Development, ...
Click on the link to read the full article at MarketWatch (press release)
(This link will open in a new window)
- GlaxoSmithKline’s Avandia still available in UK, despite MHRA call for its suspension
- Israel relaxes restrictions on medical marijuana; scientists develop new HIV/AIDS treatment
- Tough road ahead for some generics after USA’s Federal Circuit Patent Use Code decisions
- Bausch & Lomb moves to acquire Miochol-E from Novartis as required by US competition authority
- German drug price curbs will hamper orphan drug development, says BIO Deutschland
